In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genzyme BV

Division of Sanofi

Latest From Genzyme BV

CHMP's November Recommendations Include Suliqua, Vemlidy And Afstyla

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) meets monthly to review applications for EU marketing authorizations.

Approvals Drug Review

Two Psoriasis Therapies Grab CHMP Backing For European Approval

Novartis’s Cosentyx and Celgene’s Otezla are expected to be approved and launched in Europe in early 2015 for the dermatological indication.

BioPharmaceutical Europe

European Notebook Notes Arrival Of CHMP Minutes And Biosimilar MAbs

CHMP has released for the first time the minutes of its meeting, and EMA has set up a new pharmacovigilance cluster with the FDA. A biosimilar infliximab product from Hospira and Alvogen has become the first biosimilar monoclonal antibody launched in Europe.

BioPharmaceutical Europe

Sanofi Fires Up Late-Stage R&D After Growth Rekindled in Fourth Quarter

Nine late-stage products are expected to lead Sanofi’s future evolution into a developer primarily of biologics, including alirocumab for hypercholesterolemia, dupilumab for atopic dermatitis and asthma, and sarilumab for rheumatoid arthritis.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • Jan van Heek, VP & General Manager
    Erik Tambuyzer, PhD, VP, Diagnostics Business Dev., Europe
  • Contact Info
  • Genzyme BV
    Phone: (31) 2159 50102